Elanco Animal Health IncELAN

NYSEHealthcarePharmaceutical Preparations
Price (close)
$22.35
Market cap
$11.2B
P/E
—
Revenue (TTM)
$5.0B
Net income
-$199.0M
Dividend yield
—
1-year total return
18.1%
Net margin
-4.0%
Revenue growth
12.0%
Debt / equity
0.59x

What Elanco Animal Health Inc does.

Elanco Animal Health Incorporated and its subsidiaries (collectively, Elanco, the Company, we, us, or our) is a global leader in animal health, dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets. We partner with farmers, pet owners, veterinarians and society to create value and help our customers improve the health of animals in their care, while also making a meaningful impact on the communities we serve. Our diverse, durable product portfolio is sold in more than 90 countries and serves animals across many species, primarily: dogs and cats (collectively, pet health) and cattle, poultry, swine and sheep (collectively, farm animal). Our purpose – making life better for animals makes life better – inspires us to Go Beyond for animals, our customers, our people and society.

Go Beyond for Animals – Our strong portfolio, high-impact innovation, unique market approach and dedication to making life better allow us to go beyond for animals to address critical health needs and increase access to health products and services.

Go Beyond for Customers – Our ability to reach the world's animals, along with our customer promise, to advocate, earn trust and solve big challenges to create value , allows us to go beyond for our customers, unlocking economic value for producers through science-based, scalable and sustainable solutions and supporting the professional wellness of veterinarians.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$3.3B$4.8B$4.4B$4.4B$4.4B$4.7B
Net income-$574.0M-$483.0M-$78.0M-$1.2B$338.0M-$232.0M
Free cash flow-$176.0M$324.0M$281.0M$131.0M$394.0M$284.0M

More on ELAN.

Figures from Elanco Animal Health Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.